{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for penicillin root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
NCT03287908: Phase 1 Interventional Terminated Relapsed/Refractory Multiple Myeloma
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04338581: Phase 2 Interventional Active, not recruiting Vitiligo
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04701164: Phase 3 Interventional Completed Guillain-Barre Syndrome
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04505137: Phase 1 Interventional Completed Pulmonary Arterial Hypertension
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04380805: Phase 2 Interventional Completed Recurrent Cervical Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tamrintamab pamozirine [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:zirconium (⁸⁹Zr) crefmirlimab berdoxam [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:trontinemab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02898753: Phase 1/Phase 2 Interventional Terminated Pompe Disease
(2017)
Source URL:
Class:
PROTEIN